PRX-07034
PRX-07034 Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | PRX-07034 |
Generic | PRX-07034 |
Type | |
Formula | C21H29Cl2N3O4S |
Weight | Average: 490.44 Monoisotopic: 489.125583 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in alzheimer's disease, obesity, and schizophrenia and schizoaffective disorders.
How PRX-07034 works
PRX-07034 is a novel, highly selective, small-molecule antagonist of a specific G-protein coupled receptor (GPCR) known as 5-HT6 being developed for the treatment of obesity, Alzheimer's disease and cognitive impairment associated with schizophrenia.
PRX-07034 has also been shown to enhance cognitive function in preclinical animal models of memory impairment through a dual mechanism of action.It has an effect on both the acetylcholine and glutamate neurotransmitter systems in the brain, which makes it a potentially complementary therapy to cholinesterase inhibitors, a class of drugs approved for the treatment of Alzheimer's disease.
Innovators Monograph
You find simplified version here PRX-07034